Phase IV Clinical Study of Immunogenicity of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector)
Clinical trial NCT05935176 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05935176
- Sponsor
- CanSino Biologics Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-20
- Primary completion
- 2026-05-15
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.